amfAR story
Advances in antiretroviral therapy have transformed HIV from a fatal infection into a manageable chronic condition. As a result, people living with HIV are living longer than ever before—a remarkable success story for science and medicine. But longevity also brings new questions, including how HIV may interact with the biology of aging.
One area drawing growing attention is brain health. How does HIV that has been treated long-term affect cognitive aging? Could it influence the development or progression of neurodegenerative diseases, such as Alzheimer’s?
To explore these questions, Dr. Andrea Gramatica, an immunologist and VP of Research at amfAR, and Dr. Kelsey Hopland, a neuroscientist and new Program Officer, Research, at amfAR, sat down to discuss what scientists currently understand—and what remains unknown—about the intersection of HIV and neurodegeneration.
Read the full discussion here.
Source : amfAR
Related HIV and Co-Infections News
-
ACTG launches landmark study evaluating treatments for depressive disorders with or without mild neurocognitive disorder among people living with HIV
-
Florida International University: HIV disrupts lung “clock,” raising COPD and emphysema risk
-
ESCMID: HIV treatment reduces accelerated biological aging by nearly four years, landmark study shows
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.